ולוויר

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

VALACICLOVIR AS HYDROCHLORIDE 500 MG

Mevcut itibaren:

RAFA LABORATORIES LTD

ATC kodu:

J05AB11

Farmasötik formu:

FILM COATED TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

PHARMATHEN S.A., GREECE

Terapötik grubu:

VALACICLOVIR

Terapötik endikasyonlar:

Valovir is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults. Valovir accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. The efficacy of valaciclovir in immunocompromised patients has not been established.Valovir is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. Valovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). Prophylaxis of cytomegalovirus infection and disease, following organ transplantation. For the treatment of cold sores (herpes labialis).

Yetkilendirme tarihi:

2013-05-01